Literature DB >> 17010105

Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.

Xiaohua Chen1, Gregory A Hale, Raymond Barfield, Ely Benaim, Wing H Leung, James Knowles, Edwin M Horwitz, Paul Woodard, Kimberly Kasow, Usman Yusuf, Frederick G Behm, Randall T Hayden, Sheila A Shurtleff, Victoria Turner, Deo Kumar Srivastava, Rupert Handgretinger.   

Abstract

The main obstacles to successful haploidentical haematopoietic stem cell transplantation from a mismatched family member donor are delayed immune reconstitution, vulnerability to infections and severe graft-versus-host disease (GvHD). We designed a reduced-intensity conditioning regimen that excluded total body irradiation and anti-thymocyte globulin in order to expedite immune reconstitution after a CD3-depleted haploidentical stem cell transplant. This protocol was used to treat 22 paediatric patients with refractory haematological malignancies. After transplantation, 91% of the patients achieved full donor chimaerism. They also showed rapid recovery of CD3(+) T-cells, T-cell receptor (TCR) excision circle counts, TCRbeta repertoire diversity and natural killer (NK)-cells during the first 4 months post-transplantation, compared with those results from a group of patients treated with a myeloablative conditioning regimen. The incidence and extent of viremia were limited and no lethal infection was seen. Only 9% of patients had grade 3 acute GvHD, while 27% patients had grade 1 and another 27% had grade 2 acute GvHD. This well-tolerated regimen appears to accelerate immune recovery and shorten the duration of early post-transplant immunodeficiency, thereby reducing susceptibility to viral infections. Rapid T-cell reconstitution, retention of NK-cells in the graft and induction of low grade GvHD may also enhance the potential anti-cancer immune effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010105     DOI: 10.1111/j.1365-2141.2006.06330.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

1.  Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  Am J Transl Res       Date:  2011-09-10       Impact factor: 4.060

Review 2.  Overview of T-cell depletion in haploidentical stem cell transplantation.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Maurizio Caniglia; Chiara Ciammetti; Cecilia Rossi; Maria Ester Bernardo; Franco Locatelli; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

Review 3.  Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.

Authors:  Yangqiu Li; Ling Xu
Journal:  Stem Cell Investig       Date:  2015-09-28

4.  Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Christine M Hartford; Deqing Pei; Meredith J Posner; Jie Yang; Randall T Hayden; Ashok Srinivasan; Brandon M Triplett; Jon A McCulllers; Ching-Hon Pui; Wing Leung
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

5.  Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT.

Authors:  Allison L Bayer; Monica Jones; Jackeline Chirinos; Lesley de Armas; Taylor H Schreiber; Thomas R Malek; Robert B Levy
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

6.  Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients.

Authors:  H J Im; K N Koh; J K Suh; S W Lee; E S Choi; S Jang; S W Kwon; C-J Park; J J Seo
Journal:  Bone Marrow Transplant       Date:  2014-10-13       Impact factor: 5.483

Review 7.  Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.

Authors:  Mohammadreza Shaghaghi; Mona Irannejad; Hassan Abolhassani; Shohreh Shahmahmoodi; Amir Ali Hamidieh; Saeed Soleyman-Jahi; Reza Yazdani; Gholamreza Azizi; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-06-14       Impact factor: 8.317

Review 8.  Perspective on the role of haploidentical transplantation in the management of hematologic malignancies: why do it?

Authors:  Gregory A Hale
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

Review 9.  Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.

Authors:  Daniel Kl Cheuk
Journal:  World J Transplant       Date:  2013-12-24

10.  Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.

Authors:  Brandon M Triplett; Chong Wang; Jie Yang; Mari Dallas; Christine Hartford; Vanessa Howard; Asha Pillai; David Shook; Ashok Srinivasan; Joseph Laver; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-27       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.